Major Ingredients

Each capsule contains Cabozantinib 60mg as Cabozantinib (S) Malate INN.

Major Functionality

Cabozantinib is indicated for the treatment of patients with progressive, metastatic medullary thyroid cancer (MTC).

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.